LOAME
VRTX icon

Lombard Odier Asset Management (Europe)’s Vertex Pharmaceuticals VRTX Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,930
Closed -$9.66M – 173
2025
Q1 		$9.66M Buy
19,930
+957
+5% +$446K 0.78% 50
2024
Q4 		$7.64M Sell
18,973
-1,261
-6% -$585K 0.49% 74
2024
Q3 		$9.41M Sell
20,234
-9,703
-32% -$4.66M 0.4% 89
2024
Q2 		$14M Buy
+29,937
New +$13M 0.66% 41
2020
Q4 		– Sell
-2,588
Closed -$704K – 393
2020
Q3 		$704K Buy
+2,588
New +$714K 0.04% 145
2020
Q2 		– Sell
-2,588
Closed -$616K – 284
2020
Q1 		$616K Hold
2,588
– – 0.05% 142
2019
Q4 		$567K Hold
2,588
– – 0.04% 179
2019
Q3 		$438K Hold
2,588
– – 0.04% 212
2019
Q2 		$475K Hold
2,588
– – 0.04% 196
2019
Q1 		$476K Hold
2,588
– – 0.05% 178
2018
Q4 		$429K Hold
2,588
– – 0.04% 193
2018
Q3 		$499K Hold
2,588
– – 0.03% 204
2018
Q2 		$440K Hold
2,588
– – 0.03% 208
2018
Q1 		$422K Sell
2,588
-226
-8% -$36.9K 0.03% 218
2017
Q4 		$422K Sell
2,814
-368
-12% -$54.5K 0.03% 233
2017
Q3 		$484K Hold
3,182
– – 0.03% 234
2017
Q2 		$410K Hold
3,182
– – 0.02% 253
2017
Q1 		$348K Sell
3,182
-284
-8% -$25K 0.02% 258
2016
Q4 		$255K Buy
3,466
+400
+13% +$32.5K 0.09% 281
2016
Q3 		$267K Hold
3,066
– – 0.09% 295
2016
Q2 		$264K Buy
+3,066
New +$265K 0.01% 316

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s VRTX Position: Q2 2025 in Review

Lombard Odier Asset Management (Europe) sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 19,930 shares — an estimated $9.66M sold.

Lombard Odier Asset Management (Europe) first reported a position in VRTX in Q2 2016 and held it in 21 quarters. The position peaked at $14M in Q2 2024. 1,560 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Lombard Odier Asset Management (Europe) reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 19,930 Vertex Pharmaceuticals shares in Q2 2025, an estimated $9.66M.
  • Lombard Odier Asset Management (Europe) first reported a position in Vertex Pharmaceuticals in Q2 2016 and held it in 21 quarters.
  • Lombard Odier Asset Management (Europe)'s Vertex Pharmaceuticals position peaked at $14M in Q2 2024.
  • 1,560 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2025, filed 14 Aug 2025.